Proceedings of the 1st biannual bridging the gaps in lung cancer conference.

Détails

ID Serval
serval:BIB_A6408ED80877
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Proceedings of the 1st biannual bridging the gaps in lung cancer conference.
Périodique
The oncologist
Auteur⸱e⸱s
Florez N., Patel S.P., Wakelee H., Bazhenova L., Massarelli E., Salgia R., Stiles B., Peters S., Malhotra J., Gadgeel S.M., Nieva J.J., Afkhami M., Hirsch F.R., Gubens M., Cascone T., Levy B., Sabari J., Husain H., Ma P.C., Backhus L.M., Iyengar P., Lee P., Miller R., Sands J., Kim E.
ISSN
1549-490X (Electronic)
ISSN-L
1083-7159
Statut éditorial
In Press
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: aheadofprint
Résumé
Lung cancer is the leading cause of cancer death in the US and globally. The mortality from lung cancer has been declining, due to a reduction in incidence and advances in treatment. Although recent success in developing targeted and immunotherapies for lung cancer has benefitted patients, it has also expanded the complexity of potential treatment options for health care providers. To aid in reducing such complexity, experts in oncology convened a conference (Bridging the Gaps in Lung Cancer) to identify current knowledge gaps and controversies in the diagnosis, treatment, and outcomes of various lung cancer scenarios, as described here. Such scenarios relate to biomarkers and testing in lung cancer, small cell lung cancer, EGFR mutations and targeted therapy in non-small cell lung cancer (NSCLC), early-stage NSCLC, KRAS/BRAF/MET and other genomic alterations in NSCLC, and immunotherapy in advanced NSCLC.
Mots-clé
clinical decision-making, controversies, lung cancer diagnosis, lung cancer management, lung cancer treatment, unanswered questions
Pubmed
Web of science
Open Access
Oui
Création de la notice
13/09/2024 13:50
Dernière modification de la notice
31/10/2024 7:13
Données d'usage